Copy number gain of JAK2 on marker chromosome in a case of relapsed pediatric B-ALL.
作者信息
Shetty Dhanlaxmi, Talker Elizabeth, Dhamne Chetan, Mohanty Purvi, Chaubal Kruti, Tembhare Prashant, Patkar Nikhil, Subramanian P G, Moulik Nirmalya Roy, Narula Gaurav, Banavali Shripad
机构信息
Cancer Cytogenetics Department, Advanced Centre for Treatment Research and Education in Cancer (ACTREC), Tata Memorial Centre, Mumbai, India.
Homi Bhabha National Institute (HBNI), Training School Complex, Mumbai, India.
出版信息
Pediatr Blood Cancer. 2022 Oct;69(10):e29658. doi: 10.1002/pbc.29658. Epub 2022 Apr 4.
PMID:35373889
Abstract
摘要
相似文献
1
Copy number gain of JAK2 on marker chromosome in a case of relapsed pediatric B-ALL.复发性儿童B淋巴细胞白血病病例中标记染色体上JAK2基因的拷贝数增加
Pediatr Blood Cancer. 2022 Oct;69(10):e29658. doi: 10.1002/pbc.29658. Epub 2022 Apr 4.
2
Novel JAK2 rearrangement resulting from a t(9;22)(p24;q11.2) in B-acute lymphoblastic leukemia.B 急性淋巴细胞白血病中因 t(9;22)(p24;q11.2)导致的新型 JAK2 重排。
Leuk Res. 2010 Dec;34(12):1674-6. doi: 10.1016/j.leukres.2010.05.031. Epub 2010 Jul 1.
3
A novel somatic JAK2 kinase-domain mutation in pediatric acute lymphoblastic leukemia with rapid on-treatment development of LOH.小儿急性淋巴细胞白血病中一种新的体细胞JAK2激酶结构域突变，其在治疗过程中快速发生杂合性缺失。
Cancer Genet. 2017 Oct;216-217:86-90. doi: 10.1016/j.cancergen.2017.07.008. Epub 2017 Jul 31.
4
Identification of SPAG9 as a novel JAK2 fusion partner gene in pediatric acute lymphoblastic leukemia with t(9;17)(p24;q21).在伴有t(9;17)(p24;q21)的小儿急性淋巴细胞白血病中鉴定SPAG9作为一种新的JAK2融合伴侣基因。
Genes Chromosomes Cancer. 2015 Jul;54(7):401-8. doi: 10.1002/gcc.22251. Epub 2015 May 7.
5
Prognostic significance of CRLF2 overexpression and JAK2 mutation in Egyptian pediatric patients with B-precursor acute lymphoblastic leukemia.CRLF2过表达和JAK2突变在埃及B前体急性淋巴细胞白血病儿童患者中的预后意义
Clin Lymphoma Myeloma Leuk. 2022 Jun;22(6):e376-e385. doi: 10.1016/j.clml.2021.12.006. Epub 2021 Dec 11.
6
JAK2--a new player in acute lymphoblastic leukaemia.JAK2——急性淋巴细胞白血病中的新角色。
Lancet. 2008 Oct 25;372(9648):1448-50. doi: 10.1016/S0140-6736(08)61342-2. Epub 2008 Sep 19.
7
Copy number genome alterations are associated with treatment response and outcome in relapsed childhood ETV6/RUNX1-positive acute lymphoblastic leukemia.拷贝数基因组改变与复发性儿童ETV6/RUNX1阳性急性淋巴细胞白血病的治疗反应和预后相关。
Haematologica. 2014 Apr;99(4):706-14. doi: 10.3324/haematol.2012.072470. Epub 2013 Nov 15.
8
A typical acute lymphoblastic leukemia JAK2 variant, R683G, causes an aggressive form of familial thrombocytosis when germline.一种典型的急性淋巴细胞白血病JAK2变体，R683G，当为种系突变时会导致侵袭性家族性血小板增多症。
Leukemia. 2021 Nov;35(11):3295-3298. doi: 10.1038/s41375-021-01239-9. Epub 2021 Apr 12.
9
Identification of RNPC3 as a novel JAK2 fusion partner gene in B-acute lymphoblastic leukemia refractory to combination therapy including ruxolitinib.鉴定 RNPC3 为一种新型 JAK2 融合伙伴基因，其存在与包括鲁索利替尼在内的联合疗法治疗抵抗的 B 急性淋巴细胞白血病相关。
Mol Genet Genomic Med. 2020 Mar;8(3):e1110. doi: 10.1002/mgg3.1110. Epub 2019 Dec 30.
10
Clinical efficacy of ruxolitinib and chemotherapy in a child with Philadelphia chromosome-like acute lymphoblastic leukemia with fusion and induction failure.鲁索替尼与化疗对一名费城染色体样急性淋巴细胞白血病伴融合及诱导失败患儿的临床疗效
Haematologica. 2018 Sep;103(9):e427-e431. doi: 10.3324/haematol.2018.192088. Epub 2018 May 17.
引用本文的文献
1
B-cell ALL with SOX11 gene amplification associates with a worse outcome.伴 SOX11 基因扩增的 B 细胞急性淋巴细胞白血病与更差的预后相关。
Cell Cycle. 2024 Jan;23(1):36-42. doi: 10.1080/15384101.2024.2306756. Epub 2024 Feb 13.
Zotero 插件